GGrantIndex
Sort

48,018 grants matching immunotherapy

Modulation of B Cell Responses in Autoimmunity

$732,285
Eugene W. St Clair · Duke University · U19 · FY2007 · AI

Evaluation of an implantable microdevice for rapid cancer drug screening directly in T cell lymphoma patients

$732,152
Cecilia Larocca · Brigham And Women'S Hospital · R37 · FY2021 · CA

Regulation of human dendritic cell activation

$731,778
Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

(PQ5) Mitochondrial Heterogeneity in Melanoma Tumor and Immune Responses

$731,547
Gerald S Shadel · Salk Institute For Biological Studies · R01 · FY2020 · CA

Immune Dysregulation During Multiple Sclerosis Relapse

$731,251
Nitin J Karandikar · University Of Iowa · R01 · FY2016 · AI

IDENTIFYING CYTOKINES THAT ENHANCE MACROPHAGE IMMUNOTHERAPY OF COLORECTAL CANCER

$731,250
Whitehead Institute For Biomedical Research · · FY2022 · Department of the Army

A Human Antibody as an Immunotherapy for Cocaine Abuse (DP1)

$730,992
Andrew B Norman · University Of Cincinnati · DP1 · FY2013 · DA

Cellular Immunotherapy for Systemic Sclerosis

$730,718
Joana M Murad · Celdara Medical, Llc · R44 · FY2020 · AR

Rapid release paclitaxel nanoparticles for bladder cancer intravestical therapy

$730,684
Ze Lu · Optimum Therapeutics, Llc · R44 · FY2008 · CA

Standardized and Genome-Wide Clinical Interpretation of Complex Genotypes for Cancer Precision Medicine

$730,562
Obi L. Griffith · Washington University · U24 · FY2020 · CA

A novel preclinical model of spontaneous metastasis

$730,435
Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

ULK Inhibition Rewires Tumor and Immune Cell Metabolism

$730,407
Jeffrey Paul Mackeigan · Henry Ford Health + Michigan State University Health Sciences · R01 · FY2025 · CA

Understanding lung cancer genomics in patients of African ancestry

$730,400
Jian Zhang · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA

Metabolic control of malignant fates in lung cancer

$730,400
Lydia Finley · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA

Microbial- based targeting of major extracellular matrix components for improved therapy of pancreatic cancer

$730,400
Edwin Manuel · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA

Understanding lung cancer genomics in patients of African ancestry

$730,398
Jian Zhang · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA

Targeting Neuroblastoma with armed T cells

$730,382
Lawrence G Lum · University Of Virginia · R01 · FY2019 · CA

Integrating systems immunology with immunometabolism and cancer immunity

$730,271
Hongbo Chi · St. Jude Children'S Research Hospital · R35 · FY2021 · CA

(PQ7)Multi-scale Analysis of Tumor Microenvironment Heterogeneity

$730,063
Dean W Felsher · Stanford University · R01 · FY2018 · CA

The Impact of a Changing Health Care Delivery System on the Quality of Oncology Care

$730,012
Nancy L Keating · Harvard Medical School · R01 · FY2021 · CA

UNITS: The UNC / UT National Clinical Trials Network Group Integrated Translational Science Production and Consultation Center

$730,001
Jason Derek Merker · Univ Of North Carolina Chapel Hill · UG1 · FY2020 · CA

UNITS: The UNC / UT National Clinical Trials Network Group Integrated Translational Science Production and Consultation Center

$730,000
Charles M Perou · Univ Of North Carolina Chapel Hill · UG1 · FY2019 · CA

Development of botulinum neurotoxin immunotherapy, serotypes C, D, F, and G

$729,744
James D. Marks · University Of California, San Francisco · U01 · FY2007 · AI

Safety and Efficacy of SHIV Vaccine in Macaques

$729,605
University Of Kansas Medical Center · R01 · FY2004 · AI

Development of a Personalized Voxel-wise Prediction of Brain Metastases using Multi-Parametric MR Imaging to Reduce Treatment Toxicity

$729,587
Olivier Morin · University Of California, San Francisco · R01 · FY2025 · CA